David Bourn, PhD, MBA

David Bourn, PhD, MBA has over 20 years of experience in the medical field. In 2021, they are the Director of Clinical Science at 4C Medical Technologies, Inc., where they are redefining solutions for Mitral Regurgitation. Previously, they were the Director of Therapy Development at Cardialen, Inc. from 2018-2021. From 2010-2018, they were a Scientist at Respicardia, and from 2005-2010 they were a Sr. Scientist at Medtronic. From 2001-2005, they were a Research Assistant at Tulane University's Computational Cardiac Electrophysiology Group, where they planned and conducted hypotheses driven research studies and authored three manuscripts and four poster publications in peer-reviewed journals. David also held a position as a Research Assistant at the University of Alabama of Birmingham's Cardiac Rhythm Management Laboratory from 2001-2005, where they conducted optical mapping studies and data analysis and designed and constructed devices as needed to conduct experimental studies.

David Bourn holds a PhD from Tulane University in Biomedical Engineering (1999-2006), an MBA from the University of Minnesota - Carlson School of Management in the Medical Industry Leadership Program (2008-2012), an M.Engr from Tulane University in Biomedical Engineering (1999-2005), and a B.S. from Louisiana Tech University in Biomedical Engineering/Electrical Engineering (1994-1999). David also completed a Cardiac Defibrillation program at the University of Alabama at Birmingham (2001-2003).